T38.0X2
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by glucocorticoids and synthetic analogues involves the accidental or intentional ingestion or exposure to steroid medications that can lead to serious health complications. These medications are commonly prescribed for anti-inflammatory and immune system suppression but can be harmful if misused, especially when taken in doses higher than recommended or consumed intentionally for self-harm. Recognizing the risks and understanding the clinical aspects of such poisonings are crucial for effective management and prevention.
Causes & Symptoms
Clinical Causes: Intentional overdose or self-harm with glucocorticoid medications Accidental ingestion, especially in children or due to medication mismanagement Misuse or abuse of steroid drugs for performance enhancement or recreational purposes Lack of proper storage, leading to easy access by vulnerable individuals
Key Symptoms: Nausea and vomiting Abdominal pain Muscle weakness or fatigue Mood changes including depression or agitation Blood pressure fluctuations Electrolyte disturbances such as elevated blood sugar levels Swelling or fluid retention Signs of adrenal suppression, such as dizziness or fainting
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily based on patient history, including recent medication intake, and clinical presentation. Laboratory tests may include:
Treatment Protocols: Management of steroid poisoning depends on the severity and timing of exposure. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T38.0X2 a billable ICD-10 code?
Yes, T38.0X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T38.0X2?
Clinical documentation must specify the nature of Poisoning by glucocorticoids and synthetic analogues, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
